Diabetes

Answers to common questions about insulin pump therapy.

Any support you can provide to your sight-impaired patients can help keep them self-sufficient in their diabetes management.

Orforglipron, a GLP-1 receptor agonist in tablet form, has proven effective in treating obesity in a phase 3 trial, offering a potential alternative to injectable treatments like Wegovy and Ozempic.

‘The gratification that one gets when you are able to save a person's limb, that's pretty big . . .. That kind of a win doesn't occur too often in family medicine.’

Get the info you need on these new drugs, part of our drug news roundup for September.

Get the info you need on this new product, part of our drug news roundup for September.

Obesity Canada has updated its recommendations on pharmacotherapy for obesity management in adults. Have you kept up? Find out here!

Vince Lamanna, president of Novo Nordisk Canada Inc. noted the 'stigma people face when living with type 2 diabetes and obesity.'